Brain Vascular and Neurocognitive Health

Launched by THE UNIVERSITY OF TEXAS AT ARLINGTON · Jul 9, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Brain Vascular and Neurocognitive Health," is exploring how a treatment called transcranial photobiomodulation affects brain health and thinking abilities in people who may be experiencing cognitive decline or disorders like Alzheimer’s disease. The goal is to see both immediate and long-term effects of this therapy on brain blood flow and mental function.

To participate in this study, you need to be between 18 and 80 years old, and both men and women of all backgrounds are welcome. However, certain people, such as those with recent brain injuries, pregnant women, or individuals with specific medical devices like pacemakers, cannot take part. If you decide to join, you can expect to receive this non-invasive treatment and take part in assessments to help researchers understand its effects. This trial is currently recruiting participants, so if you're interested, you can reach out to learn more!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Both men and women between the ages of 18-80 and of any race/ethnicity will be included in this study.
• Exclusion Criteria:
• • Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then the investigators may still opt to proceed with data collection.
• • Abnormal results from the blood screening will not impact eligibility for the study.
• • Individuals with brain injuries/surgeries in a year before the study and individuals who can not provide consent on their own will be excluded from participation.
• • Pregnant subjects, women who are breast feeding, and children (i.e. younger than 18) will not be recruited for the study. This will be assessed via self-report.
• • If a subject has any allergies to spandex/lycra, the subject will be excluded. However, latex allergies are not contraindicated.
• • Individuals with cardiac pacemakers and/or implantable cardioverter defibrillators and individuals with epilepsy will be excluded.